Work

1153TiP A phase II, open label study to investigate the efficacy and safety of domatinostat in combination with avelumab in patients with advanced unresectable/metastatic Merkel cell carcinoma progressing on anti-PD-(L)1 antibody therapy: The MERKLIN 2 study

Year: 2020

Type: article

Source: Annals of Oncology

DOI: 10.1016/j.annonc.2020.08.1276

Authors: A.C.J. van Akkooi, P.A. Ascierto, J.C. Becker, P. Nathan, P. Nghiem, U. Ostermeier, P.G. Reimann, F. Hermann

Institutions: The Netherlands Cancer Institute, Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale", Essen University Hospital, Mount Vernon Cancer Centre, Seattle Cancer Care Alliance, University of Washington Medical Center, 4SC (Germany)

Language: English

Topic: Polyomavirus and related diseases

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

OpenAlex ID: W3089306134

FWCI: 0.081

Cites:

Cited by: 1

Related to: 10